{"acquisitions":[],"changes":[],"country":"FR","description":"Adcytherix is a biopharmaceutical company developing novel antibody-drug conjugates for cancers with high unmet need. It targets cancer patients lacking effective options. Its pipeline is built around novel ADC payloads developed by a team carried over from Emergence Therapeutics.","domain":"adcytherix.com","employees":null,"founded":2024,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","industrySources":[],"investors":[],"lat":43.296399,"lng":5.377789,"location":"Marseille","multiples":[],"name":"Adcytherix","people":[],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":113400000,"connectionsAmong":[],"currency":"EUR","date":"2025-10-01","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[],"slug":"adcytherix-com-2025-10-01-series-a","source":{"fact":"round","publisher":"sifted","retrievedAt":"2026-05-16","status":"attributed","url":null},"status":"attributed","type":"series-a","url":null}],"slug":"adcytherix-com","sources":[{"fact":"round","publisher":"sifted","retrievedAt":"2026-05-16","status":"attributed","url":null},{"fact":"existence","publisher":"adcytherix.com","retrievedAt":"2026-05-16","status":"self-reported","url":"https://adcytherix.com"},{"fact":"description","publisher":"adcytherix.com","retrievedAt":"2026-05-16","status":"self-reported","url":"https://adcytherix.com"}],"stage":"series-a","stockCard":{"asOf":"2026-11-09","facts":[],"generatedAt":"2026-11-09","state":"insufficient-evidence","tldr":[]},"techStack":["Google Cloud CDN","Four","Sentry","core-js","WebsiteBuilder","Wix","Wix eCommerce","Google Cloud","React","lodash ."],"totalRaisedUsd":145800000,"traction":[],"updatedAt":"2026-05-16","valuations":[]}